Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Multiple Sclerosis

Free Subscription Articles published in Eur Neurol Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

January 2019
1. CZARNOWSKA A, Kapica-Topczewska K, Zajkowska O, Swierzbinska R, et al
   Herpesviridae Seropositivity in Patients with Multiple Sclerosis: First Polish Study.
   Eur Neurol. 2019;80.
   PubMed     Text format     Abstract available
   
   
   
2. LADEIRA F, Salavisa M, Caetano A, Barbosa R, et al
   The Influence of Menopause in Multiple Sclerosis Course: A Longitudinal Cohort Study.
   Eur Neurol. 2019;80.
   PubMed     Text format     Abstract available
   
   
   
3. RUBERTE E, Sinnecker T, Amann M, Gaetano L, et al
   Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.
   Eur Neurol. 2019;80.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. GEBHARDT M, Kropp P, Hoffmann F, Zettl UK, et al
   Headache at the Time of First Symptom Manifestation of Multiple Sclerosis: A Prospective, Longitudinal Study.
   Eur Neurol. 2018;80.
   PubMed     Text format     Abstract available
   
   
   
5. AVILA M, Bansal A, Culberson J, Peiris AN, et al
   The Role of Sex Hormones in Multiple Sclerosis.
   Eur Neurol. 2018;80.
   PubMed     Text format     Abstract available
   
   
   August 2018
6. HOSL KM, Deutsch M, Wang R, Roy S, et al
   Sexual Dysfunction Seems to Trigger Depression in Female Multiple Sclerosis Patients.
   Eur Neurol. 2018;80.
   PubMed     Text format     Abstract available
   
   
   October 2017
7. LECAT M, Decavel P, Magnin E, Lucas B, et al
   Multiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review.
   Eur Neurol. 2017;78.
   PubMed     Text format     Abstract available
   
   
   July 2017
8. GRASSO MG, Broccoli M, Casillo P, Catani S, et al
   Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis.
   Eur Neurol. 2017;78.
   PubMed     Text format     Abstract available
   
   
   
9. GONZALES B, Chopard G, Charry B, Berger E, et al
   Effects of a Training Program Involving Body Cooling on Physical and Cognitive Capacities and Quality of Life in Multiple Sclerosis Patients: A Pilot Study.
   Eur Neurol. 2017;78.
   PubMed     Text format     Abstract available
   
   
   May 2017
10. KAUV P, Ayache SS, Creange A, Chalah MA, et al
    Adenosine Triphosphate Metabolism Measured by Phosphorus Magnetic Resonance Spectroscopy: A Potential Biomarker for Multiple Sclerosis Severity.
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available
    
    
    April 2017
11. HABEK M, Krbot Skoric M, Crnosija L, Gabelic T, et al
    Postural Orthostatic Tachycardia Predicts Early Conversion to Multiple Sclerosis after Clinically Isolated Syndrome.
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available
    
    
    March 2017
12. SAHRAIAN MA, Rezaali S, Hosseiny M, Doosti R, et al
    Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available
    
    
    
13. BURGGRAAFF J, Knol DL, Uitdehaag BM
    Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available
    
    
    January 2017
14. VILLAVERDE-GONZALEZ R, Gracia Gil J, Perez Sempere A, Millan Pascual J, et al
    Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available
    
    
    December 2016
15. MOREAU T, Bungener C, Heinzlef O, Suchet L, et al
    Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.
    Eur Neurol. 2016;77.
    PubMed     Text format     Abstract available
    
    
    October 2016
16. VERMERSCH P, Trojano M
    Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available
    
    
    
17. VILLAR-QUILES RN, Matias-Guiu JA, Ortega G, Gonzalez-Suarez I, et al
    Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available
    
    
    January 2016
18. PATTI F
    Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
    Eur Neurol. 2016;75 Suppl 1:9-12.
    PubMed     Text format     Abstract available
    
    
    
19. TROJANO M
    THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
    Eur Neurol. 2016;75 Suppl 1:4-8.
    PubMed     Text format     Abstract available
    
    
    
20. FERNANDEZ O
    THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
    Eur Neurol. 2016;75 Suppl 1:1-3.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: